EU Safety Gate (RAPEX) · France · 2025-10-24 · Serious risk
🌐Machine-translated with AI — the facts come from the issuing authority’s own notice (linked on this page); this language version was translated automatically by an AI model and is not reviewed. The original-language notice is authoritative. How we use AI →
Reported risk: Les tatouages temporaires contiennent du diéthylène glycol monobutyl éther (DEGBE), qui est interdit dans ce type de produits. Le DEGBE peut provoquer des dommages au système reproducteur. De plus, le produit ne comporte pas les avertissements clés : mélange destiné à être utilisé pour les tatouages ou le maquillage permanent, contient du nickel et de la méthylisothiazolinone, qui peuvent provoquer des réactions allergiques. Le produit ne respecte pas le règlement REACH ni le règlement sur la classification, l'étiquetage et l'emballage (CLP).
Action taken by the authority
Type of economic operator taking notified measure
Other
Category of measure
Removal of this product listing by the online marketplace
Date of entry into force
18/09/2025
Machine translation. This page was translated automatically from the English record we hold of the issuing authority’s notice. The English original is shown below and the authority’s own notice is linked above — both take precedence over this translation.
Product Name (original English): Eternal Ink
Risk Description (original English): The tattoo transfers contain diethylene glycol monobutyl ether (DEGBE), which is prohibited in these types of products. DEGBE may cause damage to the reproductive system. Additionally, the product fails to include key warnings: mixture for use in tattoos or permanent make-up, contains nickel and methylisothiazolinone, which can cause allergic reactions.
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.